Focus on IL-6 Inhibitors for Optimizing Multimodal Management of RA
A Real World Approach to Unmet Needs, Patient-Centric Care, Special Populations, and Sequencing Biologic Therapies for Rheumatoid Arthritis (RA)
A Real World Approach to Unmet Needs, Patient-Centric Care, Special Populations, and Sequencing Biologic Therapies for Rheumatoid Arthritis (RA)
Course Videos
Video
Why has IL-6 emerged as an important target for treating RA and through what mechanisms does inhibition of IL-6 affect the pathogenesis of RA?
Video
When are you inclined to use combination therapy with a DMARD and biologic, and when is monotherapy with a DMARD alone a reasonable strategy?
Video
In patients at risk for or a previous history of serious infection, are there some biologic agents that seem to lower the risk of such a complication?
Video
How do you initiate DMARD therapy and what agents or combinations do you employ?
How do you initiate DMARD therapy and what agents or combinations do you employ?
Video
How do you identify high risk patients who are likely to benefit from biological therapy?
How do you identify high risk patients who are likely to benefit from biological therapy?
Video
What are the pivotal mechanisms by which IL-6 contributes to the pathogenesis of RA?
What are the pivotal mechanisms by which IL-6 contributes to the pathogenesis of RA?
Video
What do clinical trials tell us about what strategies are optimal for RA patients who are inadequate responders to DMARDs and/or biologic therapy?
Video
What do current ACR guidelines recommend as far as sequencing therapy in patients who have had an insufficient response to methotrexate?
Video
What biomarkers and clinical findings are most useful for guiding therapy in RA?
What biomarkers and clinical findings are most useful for guiding therapy in RA?
Video
What is the evidence for early, aggressive therapy with biologics in RA?
What is the evidence for early, aggressive therapy with biologics in RA?
Video
What is the current status of B-cell targeting agents?
What is the current status of B-cell targeting agents?
Video
What are the unmet biomarker and/or therapeutic needs in patients with RA?
What are the unmet biomarker and/or therapeutic needs in patients with RA?